iBET works in a broad range of fields that encompass multidisciplinary approaches ranging from basic, technological to clinical and translational research, from the development of complex biopharmaceuticals and novel therapies to areas in food and health, including nutraceuticals development and agro-forestry.
Tuesday
More than 8M€ attributed to H2020 project CRUZIVAX for the development of a vaccine for Chagas disease
Friday
Friday
Uma Casa do Futuro, an article by Lúcia Crespo in Jornal de Negócios.
Thursday
Ana Matias, senior scientist and group leader of the Nutraceuticals and Bioactive Processes Technology group at iBET integrated the organizing committee
